Bell Potter valuation, page-124

For those saying that Mesoblast is just clutching at straws by saying the LVAD trial was a success despite not meeting the primary end point, just remember that medications like phosphodiesterase inhibitors (viagra) and minoxidil weren’t market beaters when it came to treating their primary end points of treating hypertension. What Mesoblast has proven through this recent trial is that their cells have anti inflammatory and immunomodulatory actions which have endless treatment applications over a ridiculous amount of medical conditions, especially with the significant increase in autoimmune diseases worldwide.